JA

Jagmohan Arora

Director Managing Director DIN 00154807
DIN 00154807 First appointment Aug 1983 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Aug 1983
Shareholding value β€’β€’β€’β€’ Premium profile

About Jagmohan Arora

Data last updated:

Jagmohan Arora was a Managing Director at Synokem Pharmaceuticals Limited (1983–2016). The company operates in Pharma.

Jagmohan Arora was among India's richest people in 2019 at #819.

DIN 00154807
Primary Designation Managing Director
Industry Pharma
First Appointment 01 Aug 1983

Recognitions & Rankings

India's Richest People 2019 edition · Source: Hurun India
Rank#819
Wealth
₹1,000 Cr
Company
Synokem Pharmaceuticals

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synokem Pharmaceuticals Limited U21002DL1983PLC016353
Managing Director01 Aug 19831983₹791 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Synokem Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Jagmohan Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagmohan Arora

Jagmohan Arora was first appointed on 01 Aug 1983 as Managing Director at Synokem Pharmaceuticals Limited.

Jagmohan Arora held 1 earlier board appointment: Synokem Pharmaceuticals Limited (Managing Director, 01 Aug 1983 to 21 Oct 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available